These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 1187406)

  • 21. Short-term effects of 1,25-dihydroxycholecalciferol on disordered calcium metabolism of renal failure.
    Brickman AS; Coburn JW; Norman AW; Massry SG
    Am J Med; 1974 Jul; 57(1):28-33. PubMed ID: 4600292
    [No Abstract]   [Full Text] [Related]  

  • 22. [Vitamin D metabolism and chronic kidney insufficiency].
    Schaefer K; von Herrath D; Kraft D
    Dtsch Med Wochenschr; 1973 Jul; 98(27):1338-44. PubMed ID: 4351844
    [No Abstract]   [Full Text] [Related]  

  • 23. Evaluation of the diurnal production of 1,25-dihydroxyvitamin D and vitamin D's effects on intestinal membrane organization.
    Norman AW; Miller BE; Putkey JA
    Prog Biochem Pharmacol; 1980; 17():160-7. PubMed ID: 6894193
    [No Abstract]   [Full Text] [Related]  

  • 24. Effects of 6 months therapy with 1,25 (OH)2D3 on bone disease of dialysis patients.
    Malluche HH; Goldstein DA; Massry SG
    Contrib Nephrol; 1980; 18():98-104. PubMed ID: 7353383
    [No Abstract]   [Full Text] [Related]  

  • 25. [Clinical importance of disorders of vitamin D metabolism].
    Flury W
    Schweiz Med Wochenschr; 1978 Jan; 108(4):129-33. PubMed ID: 341302
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Short-term effects of vitamin D3 and 1,25-dihydroxyvitamin D3 on osteomalacia in uremic rats fed a low calcium-low-phosphorus diet.
    Weisbrode SE
    Am J Pathol; 1981 Jul; 104(1):35-40. PubMed ID: 6266257
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of 25-hydroxy vitamin D3 in the osteomalacia of chronic renal failure.
    Eastwood JB; Stamp TC; De Wardener HE; Bordier PJ; Arnaud CD
    Clin Sci Mol Med; 1977 May; 52(5):499-508. PubMed ID: 862343
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Therapy with vitamin D and D-metabolites].
    Flury W; Haldimann B
    Schweiz Med Wochenschr; 1981 Feb; 111(9):314-21. PubMed ID: 6261326
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of 1alpha-hydroxyvitamin D3 in patients with chronic renal failure, with particular emphasis on the renal handling of phosphate.
    Madsen S; Olgaard K
    Clin Endocrinol (Oxf); 1977 Dec; 7 Suppl():85s-89s. PubMed ID: 606430
    [No Abstract]   [Full Text] [Related]  

  • 30. 1,25-dihydroxyvitamin D3 and 1, alpha-hydroxyvitamin D3 in children: biologic and therapeutic effects in nutritional rickets and different types of vitamin D resistance.
    Balsan S; Garabedian M; Sorgniard R; Holick MF; Deluca HF
    Pediatr Res; 1975 Jul; 9(7):586-93. PubMed ID: 169507
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vitamin D metabolism and hormonal interactions in kidney cell cultures.
    Henry HL
    Prog Biochem Pharmacol; 1980; 17():151-9. PubMed ID: 6259653
    [No Abstract]   [Full Text] [Related]  

  • 32. Biochemical and histological effects of 1,25 dihydroxycholecalciferol (1,25-DHCC) in the osteomalacia of chronic and failure.
    Eastwood JB; Phillips ME; de Wardener HE; Bordier J; Marie P; Arnaud CD; Norman AW
    J Urol Nephrol (Paris); 1974 Dec; 80(12):984-5. PubMed ID: 4617780
    [No Abstract]   [Full Text] [Related]  

  • 33. Controversies regarding uremia and acquired defects in vitamin D3 metabolism.
    Avioli LV
    Kidney Int Suppl; 1978 Jun; (8):S36-8. PubMed ID: 278895
    [No Abstract]   [Full Text] [Related]  

  • 34. Possible function of different renal metabolites of vitamin D in man.
    Kanis JA; Cundy T; Smith R; Heynen G; Warner GT; Lorains J; Russell RG
    Contrib Nephrol; 1980; 18():192-211. PubMed ID: 7353376
    [No Abstract]   [Full Text] [Related]  

  • 35. The effects of calciferol and its metabolites on patients with chronic renal failure. II. Calcitriol, 1 alpha-hydroxyvitamin D3, and 24,25-dihydroxyvitamin D3.
    Voigts AL; Felsenfeld AJ; Llach F
    Arch Intern Med; 1983 Jun; 143(6):1205-11. PubMed ID: 6344827
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effect of vitamin D metabolites on mineralization of bone tissue and phosphocalcium metabolism disorders in the course of vitamin D deficiency osteomalacia].
    Bordier P; Miravet L; Marie P; Guéris J; Rousselet F; Norman A; Rasmussen H; Ryckewaert A
    Rev Rhum Mal Osteoartic; 1978 Apr; 45(4):241-8. PubMed ID: 353964
    [No Abstract]   [Full Text] [Related]  

  • 37. Action of vitamin D metabolites in humans.
    Rasmussen H; Bordier P; Marie P; Miravet L; Ryckwaert A
    Trans Assoc Am Physicians; 1977; 90():380-9. PubMed ID: 611668
    [No Abstract]   [Full Text] [Related]  

  • 38. Vitamin d and the kidney.
    Hill LF; Stanbury SW
    Nephron; 1975; 15(3-5):369-86. PubMed ID: 170551
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Osteomalacia and disorders of vitamin D metabolism.
    Habener JF; Mahaffey JE
    Annu Rev Med; 1978; 29():327-42. PubMed ID: 206185
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Letter: vitamin-D metabolism in chronic renal failure.
    Wake CJ; Maddocks JL
    Lancet; 1975 Mar; 1(7905):516-7. PubMed ID: 46978
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.